Navigation Links
Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
Date:5/14/2008

- Two 4-week cohorts will evaluate R7128 1000mg BID in HCV genotype 1 treatment-naive patients and R7128 1500mg BID in HCV genotypes 2 or 3

treatment-experienced patients -

PRINCETON, N.J., May 14 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) has commenced dosing two additional cohorts of a 4-week Phase 1 study of R7128 in combination with Pegasys(R) (peginterferon alfa-2a) plus Copegus(R) (ribavirin) in both treatment-naive and treatment-experienced patients chronically-infected with hepatitis C virus (HCV) genotypes 1, 2 and 3. R7128, a prodrug of PSI-6130, is a nucleoside analogue polymerase inhibitor of HCV that is being developed through Pharmasset's collaboration with Roche.

The purpose of this 4-week study is to evaluate the safety, tolerability, pharmacokinetics and antiviral activity of R7128 in the clinically-relevant setting of combination therapy for chronic HCV infection. The previously planned Cohort 3 will continue dose-exploration with administration of R7128 1000mg twice-daily (BID) in treatment-naive patients with HCV genotype 1. Cohort 4 will evaluate R7128 1500mg BID administered in combination with Pegasys plus Copegus in treatment-experienced patients with genotypes 2 or 3 who did not achieve a sustained virologic response (SVR) with previous interferon-based therapy.

There will be 25 patients in each dose cohort with 20 patients randomized to receive R7128 and 5 patients randomized to receive placebo. After completing 4 weeks of the triple combination regimen and a follow-up period of 4 weeks of Pegasys plus Copegus, patients will receive an additional 16 to 40 weeks of open-label dosing of Pegasys plus Copegus under a separate protocol to complete the stand
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
10. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
11. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- New high priced hepatitis C drugs will increase ... $2.9 to $5.8 billion next year, according to a ... by the Pharmaceutical Care Management Association (PCMA). Milliman projects ... much as 8.6 percent in 2015 as a result ... The study finds that the majority of ...
(Date:7/29/2014)... Conn. , July 29, 2014 Numotion,s Board ... Mike Swinford will be the company,s new Chief ... highly successful 22-year career at GE where he worked primarily ... in annual revenue to over $5 billion. His most recent ... Services. "I am thrilled to join Numotion," ...
(Date:7/29/2014)... 2014  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched ... (AACC) 2014 Clinical Lab Expo today by unveiling two ... Roche is partnering with customers to redefine the value ... every day that they,re looking for a partner to ... labs and offices," said Jack Phillips , president ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Numotion Names Mike Swinford CEO 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
... Calif., June 2, 2011 Clovis Oncology, Inc. and ... they have entered into an agreement to develop an ... companion diagnostic test. The goal is to identify activating ... non-small cell lung cancer (NSCLC), including the EGFR T790M ...
... /PRNewswire-iReach/ -- The Institute for ... of gluten-free food supplements and herbs.The Institute for ... for integrative rheumatology—has launched GLUTEN-FREE REMEDIES™, a line ... a new standard of quality. Selected for the ...
Cached Medicine Technology:Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic 2Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic 3The Institute for Specialized Medicine Launches GLUTEN-FREE REMEDIES, a New Line of Gluten-free Food Supplements and Herbs. 2
(Date:7/30/2014)... The San Diego personal injury lawyers of ... that they are now offering free case reviews for individuals ... exposure. , “Symptoms of asbestos exposure can take years to ... plus years ago may just now be suffering from the ... of Melinda J. Helbock A.P.C. “We want people to know ...
(Date:7/29/2014)... VisitandCare.com today announced that ... to the company’s exclusive network to help couples struggling ... efforts — as top fertility clinics in Spain, Switzerland, ... state-of-the-art, and successful IVF treatments. , The exclusive selection ... study by professionals at VisitandCare.com. The goal is to ...
(Date:7/29/2014)... 2014 1Heart Caregiver Services’ advocacy ... focus on Brain Fitness Education brings great acceptance ... Fitness Program Director Tee Barr delivered an exceptional ... unit and the Assisted Living section of Aegis ... Director Christy Rozsa and Aegis Life Neighborhood Director ...
(Date:7/29/2014)... chemical alteration in a single human gene linked to ... give doctors a simple blood test to reliably predict ... described online in The American Journal of Psychiatry ... the function of the brain,s response to stress hormones ... be an unremarkable reaction to the strain of everyday ...
(Date:7/29/2014)... Diabetes is a common condition diagnosed in ... levels are increased, while the production of insulin is decreased. ... and which is needed by the body to regulate blood ... be very dangerous, as there are numerous complications that can ... this disorder and read a complex review of Matt Traverso's ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Offers Case Evaluations for Possible Asbestos Claims 2Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Reverse Your Diabetes Today Review Exposes Matt Traverso’s New eBook 2
... Looking for a unique, customized gift,for the animal lover ... Morris Animal Foundation (MAF) that benefits a favorite animal,-- dog, ... special gift for,anyone on your list. Many people who make ... notation in their holiday cards. A donation can be a,wonderful ...
... the body , , TUESDAY, Nov. 11 (HealthDay News) -- ... of high blood pressure in women who currently have ... new study by U.S. researchers who analyzed data from ... Lipoprotein particles carry cholesterol and triglycerides throughout the body. ...
... Chief Marketing,Executive at Online Buddies Inc., the parent ... of the Centers for Disease Control and Prevention,(CDC) ... as the site,s first Senior,Public Health Strategist. MANHUNT, ... 2,000,000 members worldwide, is the first social networking,site ...
... PRAIRIE, Minn., Nov. 11 Pam Kreager, ... Prairie, Minnesota-based Long Term,Care Group, Inc. (LTCG), ... Term Care,International Forum (LTCIF). The Long Term ... organization whose purpose is to promote,efficiency, effectiveness ...
... press release is available in French . ... created a new protein patterning technique that,s enabled them ... of a masterpiece painting. According to a new study ... from Universit de Montral, the Maisonneuve-Rosemont Hospital Research Centre, ...
... at the Yerkes National Primate Research Center, Emory University, ... and generation of several types of neural cells. Findings ... the journal Stem Cells , suggest dental pulp ... and regenerative medicine, particularly therapies associated with the central ...
Cached Medicine News:Health News:Unique Holiday Gift for Animal Lovers: A Donation to Fund Animal Health Research; Pick a Favorite Animal - Dog, Cat, Horse, All Species of Wildlife 2Health News:Lipoprotein Levels May Predict Women's Hypertension Risk 2Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2Health News:Long Term Care International Forum names LTCG's Pam Kreager as President 2Health News:New laser method reproduces art masterworks to protein patterns 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: